| 11535607 |
Isoindolines as HDAC inhibitors |
Xiaozhang Zheng, Matthew W. Martin, Jennifer R. Thomason, Bingsong Han, Aleksandra Rudnitskaya +1 more |
2022-12-27 |
| 11524966 |
Carboxamides as ubiquitin-specific protease inhibitors |
David Joseph Guerin, Zhongguo Wang, Tatiana Shelekhin, Justin Andrew Caravella, Hongbin Li +2 more |
2022-12-13 |
| 11414392 |
[6,6] fused bicyclic HDAC8 inhibitors |
Xiaozhang Zheng, Jennifer R. Thomason, Mary-Margaret Zablocki, Bingsong Han, Nicholas Barczak +4 more |
2022-08-16 |
| 11345672 |
Methods using HDAC11 inhibitors |
Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, Bingsong Han +6 more |
2022-05-31 |
| 11325917 |
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors |
David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more |
2022-05-10 |
| 11279681 |
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors |
Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more |
2022-03-22 |
| 11274084 |
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors |
Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more |
2022-03-15 |
| 11274085 |
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors |
Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more |
2022-03-15 |